Soluble Epoxide Hydrolase Inhibition Attenuates Excitotoxicity Involving 14,15-Epoxyeicosatrienoic Acid-Mediated Astrocytic Survival and Plasticity to Preserve Glutamate Homeostasis

Mol Neurobiol. 2019 Dec;56(12):8451-8474. doi: 10.1007/s12035-019-01669-8. Epub 2019 Jul 1.

Abstract

Astrocytes play pivotal roles in regulating glutamate homeostasis at tripartite synapses. Inhibition of soluble epoxide hydrolase (sEHi) provides neuroprotection by blocking the degradation of 14,15-epoxyeicosatrienoic acid (14,15-EET), a lipid mediator whose synthesis can be activated downstream from group 1 metabotropic glutamate receptor (mGluR) signaling in astrocytes. However, it is unclear how sEHi regulates glutamate excitotoxicity. Here, we used three primary rat cortical culture systems, neuron-enriched (NE), astrocyte-enriched glia-neuron mix (GN), and purified astrocytes, to delineate the underlying mechanism by which sEHi and 14,15-EET attenuate excitotoxicity. We found that sEH inhibitor 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA) and 14,15-EET both attenuated N-methyl-D-aspartate (NMDA)-induced neurite damage and cell death in GN, not NE, cortical cultures. The anti-excitotoxic effects of 14,15-EET and AUDA were both blocked by the group 1 mGluR5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP), as were their protective effects against NMDA-disrupted perineuronal astrocyte processes expressing glutamate transporter-1 (GLT-1) and subsequent glutamate uptake. Knockdown of sEH expression also attenuated NMDA neurotoxicity in mGluR5- and GLT-1-dependent manners. The 14,15-EET/AUDA-preserved astroglial integrity was confirmed in glutamate-stimulated primary astrocytes along with the reduction of the c-Jun N-terminal kinase 1 phosphorylation, in which the 14,15-EET effect is mGluR5-dependent. In vivo studies validated that sEHi and genetic deletion of sEH (Ephx2-KO) ameliorated excitotoxic kainic acid-induced seizure, memory impairment, and neuronal loss while preserving GLT-1-expressing perineuronal astrocytes in hippocampal CA3 subregions. These results suggest that 14,15-EET mediates mGluR5-dependent anti-excitotoxicity by protecting astrocytes to maintain glutamate homeostasis, which may account for the beneficial effect of sEH inhibition in excitotoxic brain injury and diseases.

Keywords: Astrocytes; C-Jun N-terminal kinase; Epoxyeicosatrienoic acids; Excitotoxicity; Glutamate transporter 1; Metabotropic glutamate receptors 5; Soluble epoxide hydrolase.

MeSH terms

  • 8,11,14-Eicosatrienoic Acid / analogs & derivatives*
  • 8,11,14-Eicosatrienoic Acid / pharmacology
  • Adamantane / analogs & derivatives
  • Adamantane / pharmacology
  • Animals
  • Astrocytes / drug effects
  • Astrocytes / metabolism
  • Astrocytes / pathology*
  • Cell Survival / drug effects
  • Cells, Cultured
  • Enzyme Inhibitors / pharmacology*
  • Epoxide Hydrolases / antagonists & inhibitors*
  • Epoxide Hydrolases / metabolism
  • Excitatory Amino Acid Transporter 2 / metabolism
  • Glutamic Acid / metabolism*
  • Hippocampus / metabolism
  • Homeostasis*
  • Kainic Acid
  • Lauric Acids / pharmacology
  • Mice, Inbred C57BL
  • Mitogen-Activated Protein Kinase 8 / metabolism
  • Models, Biological
  • N-Methylaspartate
  • Neuroglia / drug effects
  • Neuroglia / metabolism
  • Neuronal Plasticity / drug effects*
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurotoxins / toxicity*
  • Rats, Sprague-Dawley
  • Receptor, Metabotropic Glutamate 5 / antagonists & inhibitors
  • Receptor, Metabotropic Glutamate 5 / metabolism
  • Solubility

Substances

  • 12-(3-adamantan-1-ylureido)dodecanoic acid
  • Enzyme Inhibitors
  • Excitatory Amino Acid Transporter 2
  • Lauric Acids
  • Neurotoxins
  • Receptor, Metabotropic Glutamate 5
  • Glutamic Acid
  • N-Methylaspartate
  • 14,15-epoxy-5,8,11-eicosatrienoic acid
  • Mitogen-Activated Protein Kinase 8
  • Epoxide Hydrolases
  • 8,11,14-Eicosatrienoic Acid
  • Adamantane
  • Kainic Acid